Placebo to match Teriflunomide
Sponsors
Sanofi
Conditions
Relapsing Multiple Sclerosis
Phase 3
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2)
CompletedNCT04410991
Start: 2020-06-11End: 2024-07-16Updated: 2025-07-02
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)
CompletedNCT04410978
Start: 2020-06-30End: 2024-07-15Updated: 2025-07-02